Search
-
Predicting Opportunity in Emerging Therapies
We offer guidance for navigating these complex markets, emphasizing the need for robust primary market research, expert consultation, and a deep understanding of stakeholder perceptions.
-
How pharma and digital health can create compelling value stories for health insurers
Asking tough questions, understanding the business needs and care needs of a specific health insurer, and carrying this throughout your value story is necessary to differentiate your product or solution and maximize successful partnerships with health insurers.
-
Unlocking collaborative, patient-centric partnerships
Read more about Ipsos’ approach to developing sustainable, long-term partnerships and ensuring patient inclusion.
-
Oncology: the power of holistic insights
Understanding why real-world treatment in oncology can be sub-optimal – and what can be done about it.
-
Speeding Between the Gates
Read more about our agile stage-gate framework where multiple stakeholders and teams can launch an innovation without losing the initial intended promise, originality and ability to disrupt.
-
Novartis Insights Innovation Unlocks the Online Ecosystem
Every therapeutic category has its own unique online ecosystem, and the flow of information (and misinformation) can be mapped to drive online content, engagement, and channel strategies. Here’s an example.
-
‘Healthy’ Positioning That Changes Behavior
Revisit our on demand webinar featuring three requirements for positioning with the power to change behavior in healthcare.
-
Biosimilar Launch Strategy Development
A very effective approach to dealing with inherent uncertainty is scenario-based competitive gaming, especially when it is powered by dedicated supporting research. Here’s why.
-
Activating Success: Unified Marketing Measurement Best Practices
Featuring seasoned marketers, listen in as we explore best practices in data driven planning and activation.
-
Conquering Complexity: The ongoing revolution in oncology biomarker testing
The clinical management of cancer patients has undergone a remarkable evolution in the last 15 years, with the concept of personalized medicine now well-entrenched in the treatment paradigm.